Breaking News Instant updates and real-time market news.

CORT

Corcept Therapeutics

$16.76

0.21 (1.27%)

07:42
04/13/18
04/13
07:42
04/13/18
07:42

Corcept Therapeutics initiated with a Buy at Seaport Global

Seaport Global analyst Corey Davis initiated Corcept Therapeutics with a Buy and $32 price target citing long-term organic growth, Korlym remains underpenetrated in Cushing's syndrome, low consensus estimates, and upcoming relacorilant final Phase 2 data in Q3 that could act as a major catalyst.

CORT Corcept Therapeutics
$16.76

0.21 (1.27%)

03/09/18
03/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Corcept Therapeutics (CORT) initiated with a Buy at B. Riley FBR. 2. Masimo (MASI) initiated with an Overweight at Barclays. 3. Ovid Therapeutics (OVID) initiated with an Overweight at Piper Jaffray. 4. Endocyte (ECYT) initiated with an Outperform at Wells Fargo. 5. Cloudera (CLDR) initiated with a Neutral at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/08/18
RILY
03/08/18
INITIATION
Target $30
RILY
Buy
Corcept Therapeutics initiated with a Buy at B. Riley FBR
B. Riley FBR analyst David Buck started Corcept Therapeutics with a Buy rating and $30 price target. The analyst says Corcept is a "high-growth" company focused on Cushing's syndrome.
02/05/18
STFL
02/05/18
NO CHANGE
Target $20
STFL
Buy
Corcept price target lowered to $20 after 'surprise' Korlym ANDA at Stifel
Stifel analyst Adam Walsh lowered his FY21 and FY22 U.S. Korlym estimates after Corcept (CORT) announced that Teva (TEVA) submitted an ANDA for a generic version of the drug in the U.S. He said he was surprised by the timing of the ANDA, which challenges two Orange Book listed patents. Walsh, who also reduced his U.S. estimates for the second-gen Korlym replacement, relacorilant, lowered his price target on Corcept to $20 from $25, though he keeps a Buy rating on the stock.
02/05/18
PIPR
02/05/18
NO CHANGE
Target $30
PIPR
Overweight
Piper says Corcept has significant room for Korlym growth before generic entry
Piper Jaffray analyst Charles Duncan defended the fundamentals for Corcept Therapeutics (CORT) after it was disclosed that Teva (TEVA) has submitted a filing for a generic version of Korlym, arguing that the earliest a generic could enter is late 2020 and that he sees the company having significant room for growth, via scripts and pricing, before that time. Even if a generic reaches market, he sees significant commercial barriers and believes Corcept's second-gen '134 could reach market in-line with a generic entry's timeframe and offer a more-than-competitive profile. Duncan maintains his Overweight rating and $30 price target on Corcept, which is down 26% to $17.34 in late morning trading.

TODAY'S FREE FLY STORIES

SNAP

Snap

$6.82

0.01 (0.15%)

08:59
10/22/18
10/22
08:59
10/22/18
08:59
Recommendations
Snap analyst commentary  »

Snap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 07

    Nov

BSX

Boston Scientific

$36.53

-0.99 (-2.64%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SVU

Supervalu

$32.50

0.01 (0.03%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Hot Stocks
Breaking Hot Stocks news story on Supervalu »

Supervalu trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UROV

Urovant Sciences

$11.62

-0.63 (-5.14%)

08:58
10/22/18
10/22
08:58
10/22/18
08:58
Initiation
Urovant Sciences initiated  »

Urovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STRO

Sutro Biopharma

$14.55

0.03 (0.21%)

08:57
10/22/18
10/22
08:57
10/22/18
08:57
Initiation
Sutro Biopharma initiated  »

Sutro Biopharma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$58.49

0.06 (0.10%)

08:56
10/22/18
10/22
08:56
10/22/18
08:56
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.47

-0.72 (-2.47%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Recommendations
BancorpSouth analyst commentary  »

BancorpSouth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$219.28

3.3 (1.53%)

, AMD

AMD

$23.66

-2.95 (-11.09%)

08:55
10/22/18
10/22
08:55
10/22/18
08:55
Options
Notable open interest changes for October 22nd »

Friday's total…

AAPL

Apple

$219.28

3.3 (1.53%)

AMD

AMD

$23.66

-2.95 (-11.09%)

PBR

Petrobras

$15.49

0.16 (1.04%)

MU

Micron

$40.44

-0.86 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

SVMK

SurveyMonkey

$12.97

-0.78 (-5.67%)

08:53
10/22/18
10/22
08:53
10/22/18
08:53
Initiation
SurveyMonkey initiated  »

SurveyMonkey initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$47.59

0.19 (0.40%)

08:52
10/22/18
10/22
08:52
10/22/18
08:52
Conference/Events
Oracle to host investor meeting »

Financial Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 14

    Nov

EBAY

eBay

$28.73

-2.83 (-8.97%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Technical Analysis
Technical Take: eBay falls, analyst downgrades »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 03

    Mar

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

08:51
10/22/18
10/22
08:51
10/22/18
08:51
Recommendations
AbbVie analyst commentary  »

AbbVie price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PYPL

PayPal

$84.75

7.25 (9.35%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Periodicals
PayPal CFO tells Yahoo Finance no plans to spin off Venmo »

PayPal CFO John Rainey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

, AZN

AstraZeneca

$39.21

0.25 (0.64%)

08:50
10/22/18
10/22
08:50
10/22/18
08:50
Hot Stocks
Ionis Pharmaceuticals presents Phase 1b/2 data of danvatirsen »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$45.21

-1.13 (-2.44%)

AZN

AstraZeneca

$39.21

0.25 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

AEE

Ameren

$66.06

1.16 (1.79%)

08:49
10/22/18
10/22
08:49
10/22/18
08:49
Hot Stocks
Ameren Missouri to acquire 157-megawatt wind facility in northwest Missouri »

Ameren Missouri, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 11

    Nov

SALT

Scorpio Bulkers

$6.32

0.07 (1.12%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Earnings
Scorpio Bulkers reports Q3 EPS (1c), consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AAPL

Apple

$219.28

3.3 (1.53%)

08:47
10/22/18
10/22
08:47
10/22/18
08:47
Recommendations
Apple analyst commentary  »

Apple' advertising…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$40.44

-0.86 (-2.08%)

08:46
10/22/18
10/22
08:46
10/22/18
08:46
Initiation
Micron initiated  »

Micron initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$35.20

0.15 (0.43%)

08:46
10/22/18
10/22
08:46
10/22/18
08:46
Conference/Events
South Jersey Industries to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DavidsTea

$2.60

-0.11 (-4.06%)

, CRMD

CorMedix

$1.24

-0.37 (-22.98%)

08:45
10/22/18
10/22
08:45
10/22/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

DTEA

DavidsTea

$2.60

-0.11 (-4.06%)

CRMD

CorMedix

$1.24

-0.37 (-22.98%)

NBEV

New Age Beverages

$5.83

-0.73 (-11.13%)

CWH

Camping World

$21.37

0.52 (2.49%)

EWJ

iShares MSCI Japan Index Fund

$56.64

0.08 (0.14%)

NEPT

Neptune Wellness

$4.06

-0.26 (-6.02%)

QID

ProShares UltraShort QQQ

$40.24

0.13 (0.32%)

BZUN

Baozun

$39.66

0.21 (0.53%)

IQ

iQIYI

$23.56

-0.9 (-3.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JTPY

JetPay

$2.07

(0.00%)

08:45
10/22/18
10/22
08:45
10/22/18
08:45
Hot Stocks
Breaking Hot Stocks news story on JetPay 

JetPay trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRS

Global Water Resources

$10.67

0.17 (1.62%)

08:44
10/22/18
10/22
08:44
10/22/18
08:44
Hot Stocks
Global Water Resources receives extension on taxable gain »

Global Water Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JD

JD.com

$23.00

-0.335 (-1.44%)

08:44
10/22/18
10/22
08:44
10/22/18
08:44
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.15

0.96 (1.00%)

08:43
10/22/18
10/22
08:43
10/22/18
08:43
Recommendations
Walmart analyst commentary  »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.